We are comparing a new treatment called nemtabrutinib to standard options for patients with untreated chronic lymphocytic leukemia. The study aims to find out which treatment works better and is safer.
Health conditions and diseases that the clinical trial is designed to study and treat.
Small Lymphocytic Lymphoma (SLL) and Chronic Lymphocytic Leukemia (CLL) are types of blood cancers that affect lymphocytes, a kind of white blood cell. They can lead to symptoms such as swollen lymph nodes, fatigue, weight loss, and frequent infections.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
